Deploying deep learning (DL) models in medical applications relies on predictive performance and other critical factors, such as conveying trustworthy predictive uncertainty. Uncertainty estimation (UE) methods provide potential solutions for evaluating prediction reliability and improving the model confidence calibration. Despite increasing interest in UE, challenges persist, such as the need for explicit methods to capture aleatoric uncertainty and align uncertainty estimates with real-life disagreements among domain experts. This paper proposes an Expert Disagreement-Guided Uncertainty Estimation (EDUE) for medical image segmentation. By leveraging variability in ground-truth annotations from multiple raters, we guide the model during training and incorporate random sampling-based strategies to enhance calibration confidence. Our method achieves 55% and 23% improvement in correlation on average with expert disagreements at the image and pixel levels, respectively, better calibration, and competitive segmentation performance compared to the state-of-the-art deep ensembles, requiring only a single forward pass.
This paper introduces HuLP, a Human-in-the-Loop for Prognosis model designed to enhance the reliability and interpretability of prognostic models in clinical contexts, especially when faced with the complexities of missing covariates and outcomes. HuLP offers an innovative approach that enables human expert intervention, empowering clinicians to interact with and correct models' predictions, thus fostering collaboration between humans and AI models to produce more accurate prognosis. Additionally, HuLP addresses the challenges of missing data by utilizing neural networks and providing a tailored methodology that effectively handles missing data. Traditional methods often struggle to capture the nuanced variations within patient populations, leading to compromised prognostic predictions. HuLP imputes missing covariates based on imaging features, aligning more closely with clinician workflows and enhancing reliability. We conduct our experiments on two real-world, publicly available medical datasets to demonstrate the superiority of HuLP.
Predicting the likelihood of survival is of paramount importance for individuals diagnosed with cancer as it provides invaluable information regarding prognosis at an early stage. This knowledge enables the formulation of effective treatment plans that lead to improved patient outcomes. In the past few years, deep learning models have provided a feasible solution for assessing medical images, electronic health records, and genomic data to estimate cancer risk scores. However, these models often fall short of their potential because they struggle to learn regression-aware feature representations. In this study, we propose Survival Rank-N Contrast (SurvRNC) method, which introduces a loss function as a regularizer to obtain an ordered representation based on the survival times. This function can handle censored data and can be incorporated into any survival model to ensure that the learned representation is ordinal. The model was extensively evaluated on a HEad \& NeCK TumOR (HECKTOR) segmentation and the outcome-prediction task dataset. We demonstrate that using the SurvRNC method for training can achieve higher performance on different deep survival models. Additionally, it outperforms state-of-the-art methods by 3.6% on the concordance index. The code is publicly available on https://github.com/numanai/SurvRNC
Deep learning (DL) models have been advancing automatic medical image analysis on various modalities, including echocardiography, by offering a comprehensive end-to-end training pipeline. This approach enables DL models to regress ejection fraction (EF) directly from 2D+time echocardiograms, resulting in superior performance. However, the end-to-end training pipeline makes the learned representations less explainable. The representations may also fail to capture the continuous relation among echocardiogram clips, indicating the existence of spurious correlations, which can negatively affect the generalization. To mitigate this issue, we propose CoReEcho, a novel training framework emphasizing continuous representations tailored for direct EF regression. Our extensive experiments demonstrate that CoReEcho: 1) outperforms the current state-of-the-art (SOTA) on the largest echocardiography dataset (EchoNet-Dynamic) with MAE of 3.90 & R2 of 82.44, and 2) provides robust and generalizable features that transfer more effectively in related downstream tasks. The code is publicly available at https://github.com/fadamsyah/CoReEcho.
Medical data often exhibits distribution shifts, which cause test-time performance degradation for deep learning models trained using standard supervised learning pipelines. This challenge is addressed in the field of Domain Generalization (DG) with the sub-field of Single Domain Generalization (SDG) being specifically interesting due to the privacy- or logistics-related issues often associated with medical data. Existing disentanglement-based SDG methods heavily rely on structural information embedded in segmentation masks, however classification labels do not provide such dense information. This work introduces a novel SDG method aimed at medical image classification that leverages channel-wise contrastive disentanglement. It is further enhanced with reconstruction-based style regularization to ensure extraction of distinct style and structure feature representations. We evaluate our method on the complex task of multicenter histopathology image classification, comparing it against state-of-the-art (SOTA) SDG baselines. Results demonstrate that our method surpasses the SOTA by a margin of 1% in average accuracy while also showing more stable performance. This study highlights the importance and challenges of exploring SDG frameworks in the context of the classification task. The code is publicly available at https://github.com/BioMedIA-MBZUAI/ConDiSR
Automated segmentation proves to be a valuable tool in precisely detecting tumors within medical images. The accurate identification and segmentation of tumor types hold paramount importance in diagnosing, monitoring, and treating highly fatal brain tumors. The BraTS challenge serves as a platform for researchers to tackle this issue by participating in open challenges focused on tumor segmentation. This study outlines our methodology for segmenting tumors in the context of two distinct tasks from the BraTS 2023 challenge: Adult Glioma and Pediatric Tumors. Our approach leverages two encoder-decoder-based CNN models, namely SegResNet and MedNeXt, for segmenting three distinct subregions of tumors. We further introduce a set of robust postprocessing to improve the segmentation, especially for the newly introduced BraTS 2023 metrics. The specifics of our approach and comprehensive performance analyses are expounded upon in this work. Our proposed approach achieves third place in the BraTS 2023 Adult Glioma Segmentation Challenges with an average of 0.8313 and 36.38 Dice and HD95 scores on the test set, respectively.
Echocardiography has become an indispensable clinical imaging modality for general heart health assessment. From calculating biomarkers such as ejection fraction to the probability of a patient's heart failure, accurate segmentation of the heart and its structures allows doctors to plan and execute treatments with greater precision and accuracy. However, achieving accurate and robust left ventricle segmentation is time-consuming and challenging due to different reasons. This work introduces a novel approach for consistent left ventricular (LV) segmentation from sparsely annotated echocardiogram videos. We achieve this through (1) self-supervised learning (SSL) using temporal masking followed by (2) weakly supervised training. We investigate two different segmentation approaches: 3D segmentation and a novel 2D superimage (SI). We demonstrate how our proposed method outperforms the state-of-the-art solutions by achieving a 93.32% (95%CI 93.21-93.43%) dice score on a large-scale dataset (EchoNet-Dynamic) while being more efficient. To show the effectiveness of our approach, we provide extensive ablation studies, including pre-training settings and various deep learning backbones. Additionally, we discuss how our proposed methodology achieves high data utility by incorporating unlabeled frames in the training process. To help support the AI in medicine community, the complete solution with the source code will be made publicly available upon acceptance.
Medical image segmentation is a vital healthcare endeavor requiring precise and efficient models for appropriate diagnosis and treatment. Vision transformer-based segmentation models have shown great performance in accomplishing this task. However, to build a powerful backbone, the self-attention block of ViT requires large-scale pre-training data. The present method of modifying pre-trained models entails updating all or some of the backbone parameters. This paper proposes a novel fine-tuning strategy for adapting a pretrained transformer-based segmentation model on data from a new medical center. This method introduces a small number of learnable parameters, termed prompts, into the input space (less than 1\% of model parameters) while keeping the rest of the model parameters frozen. Extensive studies employing data from new unseen medical centers show that prompts-based fine-tuning of medical segmentation models provides excellent performance on the new center data with a negligible drop on the old centers. Additionally, our strategy delivers great accuracy with minimum re-training on new center data, significantly decreasing the computational and time costs of fine-tuning pre-trained models.
Variability in staining protocols, such as different slide preparation techniques, chemicals, and scanner configurations, can result in a diverse set of whole slide images (WSIs). This distribution shift can negatively impact the performance of deep learning models on unseen samples, presenting a significant challenge for developing new computational pathology applications. In this study, we propose a method for improving the generalizability of convolutional neural networks (CNNs) to stain changes in a single-source setting for semantic segmentation. Recent studies indicate that style features mainly exist as covariances in earlier network layers. We design a channel attention mechanism based on these findings that detects stain-specific features and modify the previously proposed stain-invariant training scheme. We reweigh the outputs of earlier layers and pass them to the stain-adversarial training branch. We evaluate our method on multi-center, multi-stain datasets and demonstrate its effectiveness through interpretability analysis. Our approach achieves substantial improvements over baselines and competitive performance compared to other methods, as measured by various evaluation metrics. We also show that combining our method with stain augmentation leads to mutually beneficial results and outperforms other techniques. Overall, our study makes significant contributions to the field of computational pathology.
The number of studies on deep learning for medical diagnosis is expanding, and these systems are often claimed to outperform clinicians. However, only a few systems have shown medical efficacy. From this perspective, we examine a wide range of deep learning algorithms for the assessment of glioblastoma - a common brain tumor in older adults that is lethal. Surgery, chemotherapy, and radiation are the standard treatments for glioblastoma patients. The methylation status of the MGMT promoter, a specific genetic sequence found in the tumor, affects chemotherapy's effectiveness. MGMT promoter methylation improves chemotherapy response and survival in several cancers. MGMT promoter methylation is determined by a tumor tissue biopsy, which is then genetically tested. This lengthy and invasive procedure increases the risk of infection and other complications. Thus, researchers have used deep learning models to examine the tumor from brain MRI scans to determine the MGMT promoter's methylation state. We employ deep learning models and one of the largest public MRI datasets of 585 participants to predict the methylation status of the MGMT promoter in glioblastoma tumors using MRI scans. We test these models using Grad-CAM, occlusion sensitivity, feature visualizations, and training loss landscapes. Our results show no correlation between these two, indicating that external cohort data should be used to verify these models' performance to assure the accuracy and reliability of deep learning systems in cancer diagnosis.